Sony Corporation (“Sony”) today announced that Sony, M3, Inc. (“M3”) and Illumina, Inc. (“Illumina”) have agreed to form a collaboration to launch a “genome information platform” in Japan. Sony and M3 will establish a new company with Illumina as a minority investor, by the end of February, 2014. Genome research, which analyzes human genetic data […]
Ebersberg, Germany. Leading NGS service company joins Life Technologies’ global network of next generation-based exome sequencing provider. Eurofins MWG Operon, a leader in next generation sequencing services has expanded its exome sequencing services with the Ion Proton Next Generation Sequencer. Certification for Ion AmpliSeq Exome sequencing was also awarded after joining Life Technologies Corporation’s Ion […]
ST. LOUIS, MO – Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine, is partnering with the Undiagnosed Diseases Program (UDP) at the National Institutes of Health (NIH) to implement a unique genetic-analysis pipeline for patient diagnosis. Assembled by the NIH and brought into production by Appistry, the pipeline considers […]
New York, NY. The New York Genome Center (NYGC) announced the acquisition from Illumina of a HiSeq X Ten system, which is expected to enable ultra-high throughput sequencing of whole human genomes. This advanced technology is designed to provide a prompt readout of the entire genome, dramatically enhancing the turnaround for valuable genomic information. With […]
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of its new Next Generation Sequencing services for microRNAs and other RNAs. Exiqon’s Next Generation Sequencing services provide a complete sample-to-answer solution including biological interpretation of customer’s results. Results are delivered within 4-6 weeks of sample submission. […]
BALTIMORE – Sapio Sciences is pleased to announce the release of Exemplar NGS LIMS™. Sapio’s NGS LIMS system will track multiple next-generation sequencing (NGS) platform workflows from request through processing and analysis. Sapio has gained extensive expertise over 5+ years of working with prominent NGS labs resulting in the industry’s leading solution for this important […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today unveiled a strategic roadmap for moving next-generation sequencing (NGS) into new markets, leveraging its technology leadership and new organizational alignment around those markets to drive growth. During an investor day where executives presented plans for this growth, Illumina also shared workflow innovations designed to simplify the sequencing experience […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced the immediate availability of a transformative addition to its industry-leading next-generation sequencing portfolio with the launch of the NextSeq 500 System. The new sequencer packs high-throughput performance into an affordable desktop form factor, enabling researchers to perform the most popular sequencing applications in less than a day. […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today broke the ‘sound barrier’ of human genomics by enabling the $1,000 genome. This achievement is made possible by the new HiSeq X Ten Sequencing System. This platform includes dramatic technology breakthroughs that enable researchers to undertake studies of unprecedented scale by providing the throughput to sequence tens of […]
Seattle, Wash. – Stratos Genomics Inc. today announced it has achieved a break-through in the reduction of the SBX™ (Sequencing by Expansion™) probe library. The original commercialization path for SBX was a 256 tetramer probe library. An undisclosed $2 million Series A-5 funding closed in the fall of 2013 based on demonstrated sequence reads of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
